Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 5 days ago

      After dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug

    • Telehealth’s uncertain future

      Politico· 3 days ago

      How we got here: According to the report, enrollees estimate their income for the following year when signing up for a plan, with a reconciliation process later when a person ...